AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 273: E908-E914, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pørksen, N.
Right arrow Articles by Schmitz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pørksen, N.
Right arrow Articles by Schmitz, O.
Vol. 273, Issue 5, E908-E914, November 1997

In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts

Niels Pørksen1, Birgit Nyholm1, Johannes D. Veldhuis2, Peter C. Butler3, and Ole Schmitz1

1 Department of Endocrinology and Metabolism M, Aarhus University Hospital, 8000 Aarhus, Denmark; 2 Department of Medicine, University of Virginia, and National Science Foundation Center for Biological Timing, Charlottesville, Virginia 22908; and 3 Department of Medicine, The University of Edinburgh, Edinburgh EH4 2XU, Scotland, United Kingdom

Detection of insulin secretory bursts in peripheral blood is hampered by hepatic insulin extraction, dilution in the systemic insulin pool, and time-delayed damping of secretory burst amplitude. Previous studies in dogs in vivo and other experiments in vitro have shown that ~70% of all insulin is released within distinct insulin secretory bursts. To establish a method for detection and quantification of pulsatile insulin release in humans on the basis of peripheral insulin concentration measurements, we used a high-sensitivity, -specificity, and -precision insulin enzyme-linked immunosorbent assay (ELISA) and optimized an established deconvolution methodology to quantify the frequency, mass, and amplitude of insulin secretory bursts as well as to estimate the relative contribution of pulsatile insulin release to overall insulin secretion. By use of minutely sampled serum insulin concentrations measured by a highly sensitive insulin ELISA, and insulin kinetics of 2.8 min (first half-life), 5.0 min (second half-life), and a fractional slow component of 0.28, the deconvolved insulin secretion rates in 20 healthy subjects during glucose infusion (4.5 mg · kg-1 · min-1) could be resolved into a series (4.7 ± 0.1 min/pulse) of approximately symmetric insulin secretory bursts with a mean mass of 87 ± 12 pmol · l-1 · pulse-1 and a mean amplitude (maximal release rate) of 35 ± 4.7 pmol · l-1 · min-1. The relative contribution of pulsatile to overall insulin secretion was 75 ± 1.6% (range 59-85%). We conclude that in vivo insulin secretion in humans during nominal glucose stimulation consists of a series of punctuated insulin secretory bursts accounting for >= 75% of total insulin secretion.

oscillations; glucose; C-peptide; amplitude


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Ritzel, J. D. Veldhuis, and P. C. Butler
The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E750 - E756.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. S. Nunemaker, D. H. Wasserman, O. P. McGuinness, I. R. Sweet, J. C. Teague, and L. S. Satin
Insulin secretion in the conscious mouse is biphasic and pulsatile
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E523 - E529.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. G. Pedersen, R. Bertram, and A. Sherman
Intra- and Inter-Islet Synchronization of Metabolically Driven Insulin Secretion
Biophys. J., July 1, 2005; 89(1): 107 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. S. Mao, N. Berman, and E. Ipp
Loss of entrainment of high-frequency plasma insulin oscillations in type 2 diabetes is likely a glucose-specific {beta}-cell defect
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E50 - E54.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Bergsten, J. Westerlund, P. Liss, and P.-O. Carlsson
Primary In Vivo Oscillations of Metabolism in the Pancreas
Diabetes, March 1, 2002; 51(3): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Porksen, T. Grofte, J. Greisen, A. Mengel, C. Juhl, J. D. Veldhuis, O. Schmitz, M. Rossle, and H. Vilstrup
Human insulin release processes measured by intraportal sampling
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E695 - E702.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. B. Juhl, M. Hollingdal, J. Sturis, G. Jakobsen, H. Agerso, J. Veldhuis, N. Porksen, and O. Schmitz
Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 424 - 429.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Gilon, M. A. Ravier, J.-C. Jonas, and J.-C. Henquin
Control Mechanisms of the Oscillations of Insulin Secretion In Vitro and In Vivo
Diabetes, February 1, 2002; 51(90001): S144 - 151.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. T. Kennedy, L. M. Kauri, G. M. Dahlgren, and S.-K. Jung
Metabolic Oscillations in {beta}-Cells
Diabetes, February 1, 2002; 51(90001): S152 - 161.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Bergsten
Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations
Diabetes, February 1, 2002; 51(90001): S171 - 176.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz
Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes
Diabetes, February 1, 2002; 51(90001): S245 - 254.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Juhl, T. Grofte, P. C. Butler, J. D. Veldhuis, O. Schmitz, and N. Porksen
Effects of Fasting on Physiologically Pulsatile Insulin Release in Healthy Humans
Diabetes, February 1, 2002; 51(90001): S255 - 257.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. L. Kjems, B. M. Kirby, E. M. Welsh, J. D. Veldhuis, M. Straume, S. S. McIntyre, D. Yang, P. Lefebvre, and P. C. Butler
Decrease in {beta}-Cell Mass Leads to Impaired Pulsatile Insulin Secretion, Reduced Postprandial Hepatic Insulin Clearance, and Relative Hyperglucagonemia in the Minipig
Diabetes, September 1, 2001; 50(9): 2001 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. B. Juhl, N. Porksen, S. M. Pincus, A. P. Hansen, J. D. Veldhuis, and O. Schmitz
Acute and Short-Term Administration of a Sulfonylurea (Gliclazide) Increases Pulsatile Insulin Secretion in Type 2 Diabetes
Diabetes, August 1, 2001; 50(8): 1778 - 1784.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Ritzel, M. Schulte, N. Pørksen, M. S. Nauck, J. J. Holst, C. Juhl, W. März, O. Schmitz, W. H. Schmiegel, and M. A. Nauck
Glucagon-Like Peptide 1 Increases Secretory Burst Mass of Pulsatile Insulin Secretion in Patients With Type 2 Diabetes and Impaired Glucose Tolerance
Diabetes, April 1, 2001; 50(4): 776 - 784.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. Laedtke, L. Kjems, N. Porksen, O. Schmitz, J. Veldhuis, P. C. Kao, and P. C. Butler
Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E520 - E528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. B. Juhl, N. Porksen, J. Sturis, A. P. Hansen, J. D. Veldhuis, S. Pincus, M. Fineman, and O. Schmitz
High-frequency oscillations in circulating amylin concentrations in healthy humans
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E484 - E490.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Porksen, C. Juhl, M. Hollingdal, S. M. Pincus, J. Sturis, J. D. Veldhuis, and O. Schmitz
Concordant induction of rapid in vivo pulsatile insulin secretion by recurrent punctuated glucose infusions
Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E162 - E170.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online